Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia) in the human prostate: An immunohistochemical and in situ hybridization study

Prostate

Volumn 29, Issue 3, 1996, Pages 137-145

  Leav, Irwin ^a   McNeal, John E ^b   Kwan, Paul W L ^b   Komminoth, Paul ^b   Merk, Frederick B ^b  

^a TUFTS UNIVERSITY   (United States)

^b NONE

Author keywords

androgen receptor; immunohistochemistry; in situ hybridization; P.I.N.; prostatic dysplasia; prostatic intraepithelial neoplasia

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; BASAL CELL; CARCINOMA IN SITU; CELL DIFFERENTIATION; CLINICAL ARTICLE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE TUMOR; PROTEIN LOCALIZATION; SECRETORY CELL;

AGED; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA, MESSENGER;

EID: 0029825212     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0045(199609)29:3<137::AID-PROS2990290302>3.0.CO;2-Z     Document Type: Article

References (39)

1. Bruchovsky N, Lesser B, Van Doorn E, Craven S: Hormonal effects on cell proliferation in rat prostate. Vitam Horm 33:61-102, 1975.
2. Bruchovsky N, Rennie PS, Van Doorn E: Pathological growth of androgen sensitive tissues resulting from latent actions of steroid hormones. J Toxicol Environ Health 4:391-408, 1978.
3. Tuohimaa P: Control of cell proliferation in male accessory sex glands, In Spring-Mills E, Hafez ESE (eds): "Male accessory sex glands." Amsterdam : Elsevier/ North-Holland Biomedical Press, 1980, pp 131-153.
4. Menon M, Walsh PC: Hormonal therapy for prostate cancer. In Murphy GP (ed): "Prostate Cancer." Littleton, MA: PSP Publishing Co., 1979, pp 75-200.
5. McNeal JE: Morphogenesis of prostatic carcinoma. Cancer 18:1659-1666, 1965.
6. McNeal JE, Bostwick GD: Intraductal dysplasia: A premalignant lesion of the human prostate. Hum Pathol 17:64-71, 1986.
7. McNeal JE: Significance of duct-acinar dysplasia in prostatic carcinogenesis. Prostate 13:91-102, 1988.
8. Bostwick DG, Brawer MK: Prostatic intraepithelial neoplasia and early invasion in prostate cancer. Cancer 59: 788-794, 1987.
9. McNeal JE, Villers A, Redwine EA, Freiha FS, Stamey TA: Microcarcinoma in the prostate: Its association with duct-acinar dysplasia. Hum Pathol 22:644-652, 1991.
10. Amin MB, Ro Jae Y, Ayala AG: Putative precursor lesions of prostatic adenocarcinoma: Fact or fiction? Mod Pathol 6:476-482, 1993.
11. Epstein JI, Cho KR, Quinne BB: Relationship of severe dysplasia to stage A (incidental) adenocarcinoma of the prostate. Cancer 65:231-2327, 1990.
12. Bostwick DG: Prostatic intraepithelial neoplasia (PIN): Current concepts. J Cell Biochem Suppl 16H:10-19, 1992.
13. McNeal JE, Haillot O, Yemoto C: Cell proliferation in dysplasia of the prostate: Analysis by P.C.N.A. immunohistochemistry. Prostate 27:258-268, 1995.
14. McNeal JE, Alroy J, Leav I, Redwine EA, Freiha FS, Stamey TA: Immunohistochemical evidence for impaired cell differentiation in premalignant phase of prostate carcinogenesis. Am J Clin Pathol 90:23-32, 1988.
15. McNeal JE, Leav I, Alroy J, Skutelsky E: Differential lectin staining of central and peripheral zones of prostate and alterations in dysplasia. Am J Clin Pathol 89: 41-48, 1988.
16. de Vries CR, McNeal JE, Bensch K: The prostatic epithelial cell in dysplasia: An ultrastructural perspective. Prostate 21:209-221, 1992.
17. Ruizeveld de Winter JA, Trapman J, Vermey M, Mulder E, Zegers ND, Van der Kwast TH: Androgen receptor expression in human tissues: An immunohistochemical study. J Histochem Cytochem 39:927-936, 1991.
18. Zegers ND, Classen E, Neelen C, Mulder E, Van Lear JH, Voorhost MM, Berrevotes CA, Brinkman AO, Van der Kwast TH, Ruizeveld de Winter JA, Trapman J, Boersma WJA: Epitope prediction and conformation for the human androgen receptor: Generation of monoclonal antibodies for multiassay performance following the synthetic peptide strategy. Biochem Biophys Acta 1073:23-32, 1991.
19. Chang C, Kokontis J, Liao S: Structural analysis of complimentary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci 85: 7211-7215, 1988.
20. 35S- and digoxigenin-labeled RNA and oligonucleotide probes for in situ hybridization. Expression of mRNA of the seminal vesicle protein II and androgen-receptor genes in the rat prostate. Histochemistry 98:217-218, 1992.
21. Takeda H, Chodak G, Mutchnik S, Nakamoto T, Chang C: Immunohistochemical localization of androgen receptors with mono- and polyclonal antibodies to androgen receptor. J Endocrinol 126:17-25, 1990.
22. Oomens EHGM, Van Steen Brugge GJ, Van der Kwast TH, Schroder FH: Application of the monoclonal antibody Ki-67 on prostate biopsies to assess the proliferative cell fraction of human prostatic carcinoma. J Urol 145:81-85, 1991.
23. Claus S, Wringer M, Senge T, Schulze H: Immunohistochemical determination of age related proliferation rates in normal and benign hyperplastic human prostates. Urol Res 21:305-308, 1993.
24. Bonkhoff H, Stein U, Remberger K: The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 24:114-118, 1994.
25. McNeal JE, Reese JH, Redwine EA, Freiha FS, Stamey TA: Cribiform adenocarcinoma of the prostate. Cancer 58:1714-1719, 1986.
26. Buick RN, Pollak MN: Perspective on clonogenic tumor cells, stem cells, and oncogenes. Cancer Res 44:4909-4918, 1984.
27. Sell S, Pierce BG: Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 70: 6-21, 1994.
28. Potten CS, Loeffler M: Stem cells: Attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110:1001-1019, 1990.
29. Mao P, Angrist A: The fine structure of the basal cell of human prostate. Lab Invest 15:1768-1782, 1966.
30. Merchant DJ, Clarke SM, Ives K, Harris S: Primary explant culture: An in vitro model of the human prostate. Prostate 4:523-542, 1983.
31. Timms BJ, Chandler JA, Sinowatz F: The ultrastrucrure of basal cells of rat and dog prostate. Cell Tissue Res 173:543-554, 1986.
32. Evans GS, Chandler JA: Cell proliferation studies in rat prostate 1. The proliferative role of basal and secretory epithelial cells during normal growth. Prostate 10:164-178, 1987.
33. Steiner MS: Role of peptide growth factors in the prostate: A review. Urology 42:99-110, 1993.
34. Ware JL: Prostate cancer progression. Implications of histopathology. Am J Pathol :983-993, 1994.
35. Cunha GR, Taguchi O, Shannon JM, Chung LWK, Bigsby RM: Mesenchymal role in hormone-induced epithelial development. In Serio M, Zanisi M, Motta M, Martini L (eds): "Sexual Differentiation: Basic and Clinical Aspects." New York: Raven Press, 1984, pp 33-51.
36. Maygarden SJ, Strom S, Ware JL: Localization of epidermal growth factor receptor by immunocytochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia and benign hyperplasia. Arch Pathol Lab Med 116:269-273, 1992.
37. Meyers RB, Srivastava S, Oelschlager DK, Grizzle WE: Expression of p 160 erbB-3 and p 185 erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J Natl Cancer Inst 86:1140-1145, 1994.
38. Merk FB, Ofner P, Kwan PW-L, Leav I, Vena RL: Ultrastructural and biochemical expressions of divergent differentiation in prostates of castrated dogs treated with estrogen and androgen. Lab Invest 47:437-450, 1982.
39. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R: Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone refractory human prostate cancers. Am J Pathol 390-400, 1993.